NCT06775457View on ClinicalTrials.gov

Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
SARS CoV-2Kawasaki DiseaseRetrovirus Infection
Interventions
OTHER

sample collection

Blood samples and fecal samples will be taken from patients during evaluation visits. Blood samples will be analyzed for the study of HERVs. While fecal samples will be analyzed for the characterization of gut microbiota.

Trial Locations (5)

10126

RECRUITING

Ospedale Regina Margherita, Torino, UO Reumatologia Pediatrica, Torino

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva, Bologna

41012

RECRUITING

Ospedale Ramazzini di Carpi, Azienda USL di Modena UO Pediatria, Carpi

41100

RECRUITING

Azienda Ospedaliera-Universitaria di Modena, Modena

00165

RECRUITING

IRCCS Ospedale Pediatrico Bambino Gesù UOC Pediatria Generale, Roma

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER